Drug Price Reforms Promise Relief For Medicare Users New legislation and state initiatives aim to curb soaring pharmaceutical costs over the coming years, offering significant savingsAs John Roberts, a 72-year-old Medicare beneficiary, sat down with his morning coffee, his phone buzzed with a notification: Medicare's long-debated plan to cap drug prices had finally come into effect. Medicare Part D enrollees who reach the “catastrophic coverage” threshold will no longer have to pay any out-of-pocket costs. Additionally, President Joe Biden has announced plans to push Congress to extend the $35 insulin out-of-pocket cap across all insurance plans, not just Medicare. On the state level, several initiatives are also in motion to lower drug prices. These include drug importation laws, the establishment of drug affordability boards, and capping out-of-pocket costs for essential medications like insulin.

Source: New York Times July 20, 2024 05:11 UTC